Why Primary Patents Covering Biologics Should Be Unforceable against Generic Applicants under the Biologics Price Competition and Innovation Act
Heled, Yaniv
Abstract
No document text available, use the download button to read the official PDF.
Chat with this journal article using AI
Ask CiteLaw's AI Navigator anything about this journal article, verify citations, and research related authorities. Sign up for CiteLaw free today to get started.